+ - BPC-157 shows promise in animal studies with few serious side effects, but human data is limited, with potential risks including injection site issues (pain, swelling, infection) and theoretical concerns like pathological angiogenesis (tumor growth) or hormonal imbalance
Cai Y, Wang Z, Liu X, Wei L, Li S, Zheng X, Xu X
In-office treatments tend to outperform at-home serums because exosomes are fragile, temperature-sensitive, and often unstable outside clinical settings
Health Canada has not approved BPC-157 as a health product or prescription drug
Pregnancy and breastfeeding are also contraindicated due to a lack of safety data for systemic use in these populations
It wont replace diet, training, or sleep